TrivarX Limited ABN 58 008 130 336 Annual report for the financial year ended 30 June 2026 TrivarX Limited Contents 30 June 2026 1 Corporate directory 2 Chair’s Letter 3 Chief Executive Officer’s Letter 5 Directors’ report 7 Auditor’s independence declaration 22...
2026 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Stabl-Im Clinical Development Update
- Notice of AGM and Closing Date for Director Nominations
- Appendix 4E - Preliminary Final Report
- June 2026 Quarterly Activities Report and Appendix 4C
- Stabl-Im clinical trial supply milestone achieved
Later from TrivarX
- Corporate Governance Statement
- Appendix 4G
- Notification of cessation of securities - TRI
- Change of Director's Interest Notice - Chris Ntoumenopoulos
- Change of Director's Interest Notice - David Trimboli
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX